GlassScriptPhysician profile
Yusha Liu
NPI 1063866069
$14,080.99
in general payments reported to CMS, 2019-2025
7 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $486 · 2023: $11K · 2024: $1,664 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $1,930 · Food and Beverage: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $1,929.80 |
| Food and Beverage | $1,665.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2023 | |
| Checkpoint Surgical, INC | $2,720.50 | 2024-2025 | Checkpoint Stimulators |
| Acumed LLC | $540.60 | 2022-2023 | Acumed, Osteomed |
| Trimed, INC. | $350.00 | 2022 | |
| Axogen | $341.28 | 2023 | Avance Nerve Graft |
| Globus Medical, INC. | $96.76 | 2023 | Mini Fragment System |
| Evolution Surgical, INC | $31.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yusha Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.